Efficacy and Safety of Fenofibrate in Patients with Hyperuricemia
Background: Allopurinol is the most frequently used antihyperuricemic drug. Fenofibrate, a derivative of fibric acid, is commonly used in the treatment of hyperlipidemia. Fenofibrate treatment has been shown to decrease serum uric acid levels. This study was conducted to assess the efficacy and sa...
Main Authors: | Irfan Zafar, Moosa Khan, Syed Mohsin Turab, Rafeeq Alam Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Dow University of Health Sciences
2012-04-01
|
Series: | Journal of the Dow University of Health Sciences |
Online Access: | http://www.jduhs.com/index.php/jduhs/article/view/25 |
Similar Items
-
Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population
by: Piyush Patel, et al.
Published: (2016-01-01) -
The efficacy and safety of febuxostat versus allopurinol in gout patients with hyperuricemia
by: Jung-Yi Chen, et al.
Published: (2016) -
Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
by: Fernando Pérez-Ruiz, et al.
Published: (2019-05-01) -
Evaluating efficacy and safety of differential therapy with atorvastatin, fenofibrate and their combination in patients with type 2 diabetes
by: G. A. Batrak
Published: (2015-12-01) -
Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients
by: Sofue T, et al.
Published: (2014-02-01)